Stay updated on Moderna Press Releases
Sign up to get notified when there's something new on the Moderna Press Releases page.
Latest updates to the Moderna Press Releases page
- Check7 days agoChange DetectedNew press releases and headlines with dates were added to the News and Blog Posts page, expanding coverage of Moderna’s corporate updates, conferences, collaborations, and financial results. Stock price and trading volume indicators in the header were updated to reflect current market data.SummaryDifference7%
- Check13 days agoChange DetectedStock price and volume display added ($41.99, 9.99M); several older press releases were removed from the News and Blog Posts list.SummaryDifference4%
- Check21 days agoChange DetectedAdded a new press release about the Recordati collaboration for mRNA-3927 and announced Dr. David Berman as Chief Development Officer (Jan 29–30, 2026). Updated stock quote data from $45.45/15.26M to $42.20/9.37M.SummaryDifference2%
- Check28 days agoChange DetectedStock quote updated from $43.00 / 12.60M to $45.45 / 15.26M, and a new press release headline 'Moderna to Report Fourth Quarter 2025 Financial Results on Friday, February 13, 2026' dated January 26, 2026 appears on the News page.SummaryDifference1%
- Check35 days agoChange DetectedNew 2026 press releases were added to the News and Blog Posts page, including Moderna's regulatory submissions for the seasonal influenza vaccine, 44th JPMorgan conference updates, and the Intismeran Autogene data with KEYTRUDA; stock data showing price and volume ($43.00, 12.60M) are displayed.SummaryDifference3%
- Check49 days agoChange DetectedThe News page year filter was updated to include 2026 and remove 2025, changing which press releases appear.SummaryDifference0.3%
Stay in the know with updates to Moderna Press Releases
Enter your email address, and we'll notify you when there's something new on the Moderna Press Releases page.